Holding(s) in Company

RNS Number : 3995Z
Intl. Biotechnology Trust PLC
06 March 2013
 



 

TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

 

2. Reason for the notification (please place an X inside the appropriate bracket/s):

 

An acquisition or disposal of voting rights: (X)

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ()

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ()

 

An event changing the breakdown of voting rights: ()

 

Other (please specify): ()

 

3. Full name of person(s) subject to the notification obligation (iii):

 

Baillie Gifford & Co

 

4. Full name of shareholder(s) (if different from 3.) (iv):

 

 

5. Date of the transaction (and date on which the threshold is crossed or reached if different) (v):

 

5 March 2013

 

6. Date on which issuer notified:

 

6 March 2013

 

7. Threshold(s) that is/are crossed or reached (vi, vii):

 

5%

 

8. Notified details:

 

A: Voting rights attached to shares (viii, ix)

 

 

Class/type of shares if possible using the ISIN CODE

Situation previous to the Triggering transaction (vi)



Number of shares


Number of voting Rights (viii)


Ordinary Shares

GB0004559349

3,037,333

3,037,333

 

 

Resulting situation after the triggering transaction (vii)

 

Class/type of shares if possible using the ISIN CODE

Number of shares

Number of voting rights

% of voting rights (x)







Direct (xi)


Indirect (xii)


Direct


Indirect

Ordinary Shares

GB0004559349

Below 5%

Below 5%


Below 5%


 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial instrument


Expiration Date (xiii)




Exercise/Conversion Period/ Date (xiv)



Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights




N/A

N/A

N/A

N/A

N/A

 

 

C: Financial Instruments with similar economic effect to Qualify Financial Instruments (xv, xvi)

Resulting situation after the triggering transaction

 

Type of financial instrument

Exercise price



Exercise date xvii

Exercise/Conversion Period xviii


Number of voting rights instrument refers to

% of voting rights xix, xx







Nominal

Delta

N/A

N/A

NA

N/A

N/A

N/A

N/A

 

 

Total (A+B+C)

Number of voting rights


% of voting rights


Below 5%

Below 5%

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xxi):

 

In the narrative below, the figures in [ ] indicate the amount of voting rights and the percentage held by each controlled undertaking where relevant.

Baillie Gifford & Co, a discretionary investment manager, is the parent undertaking of an investment management group.

Its wholly-owned subsidiary undertaking Baillie Gifford & Co Limited [below 5%] is an OEIC Authorised Corporate Director and Unit Trust Manager which has delegated its discretionary investment management role to Baillie Gifford & Co.

Proxy Voting:

 

10. Name of the proxy holder:

 

N/A

 

11. Number of voting rights proxy holder will cease to hold:

 

N/A

 

12. Date on which proxy holder will cease to hold voting rights:

 

N/A

 

13. Additional information:

 

N/A

 

14. Contact name:

 

Gillian Wright

 

15. Contact telephone number:

 

0131 275 3041

                         

Date: 6 MARCH 2013


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUNUSROWAORAR
Investor Meets Company
UK 100